Loading
NASDAQHealthcareMedical - Diagnostics & Research
Latest quote
$504.7
−$1.83 · -0.36%
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Previous close
$504.7
−$1.83 · -0.36%
Pre-market
$505.49
+$0.79 · +0.16%
Sep 14, 7:03 AM ET
Regular session · ET · Market data may be delayed.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Day range
Current $504.7
52-week range
Current $504.7
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
64
Undervalued
Sentiment
68
Bullish
Risk
43
Elevated Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Day range
Current $504.7
52-week range
Current $504.7
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.3B USD | 3.9B USD | 3.66B USD | 3.37B USD | 3.22B USD |
| Cost of goods sold | 1.64B USD | 1.52B USD | 1.47B USD | 1.36B USD | 1.33B USD |
| Gross profit | 2.66B USD | 2.38B USD | 2.19B USD | 2B USD | 1.89B USD |
| Research and development | 251.21M USD | 219.79M USD | 190.95M USD | 254.82M USD | 161.01M USD |
| Selling, general, and administrative | 1.05B USD | 1.03B USD | 901.89M USD | 850.75M USD | 796.4M USD |
| Operating expenses | 1.3B USD | 1.25B USD | 1.09B USD | 1.11B USD | 957.4M USD |
| Interest income | 2.42M USD | 12.7M USD | 5.63M USD | 1.07M USD | 434K USD |
| Interest expense | 38.27M USD | 31.21M USD | 41.58M USD | 39.86M USD | 29.81M USD |
| Depreciation and amortization | 106.46M USD | 129.94M USD | 114.91M USD | 111.9M USD | 104.6M USD |
| Operating income | 1.36B USD | 1.13B USD | 1.1B USD | 898.77M USD | 932.03M USD |
| Net income | 1.06B USD | 887.87M USD | 845.04M USD | 679.09M USD | 744.85M USD |
Company facts updated Sep 14, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 16, 2015 | 2:1 | — | — |
Stock split | Nov 27, 2007 | 2:1 | — | — |
Stock split | Jun 6, 1995 | 2:1 | — | — |
Stock split | Oct 4, 1993 | 2:1 | — | — |
Effective Jun 16, 2015
2:1
Effective Nov 27, 2007
2:1
Effective Jun 6, 1995
2:1
Effective Oct 4, 1993
2:1
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.4B0.06%2.3T USD0.03%$376.31+0.82%
Vanguard S&P 500 ETFVOO1.16B0.07%1.7T USD0.03%$702.56+0.85%
Vanguard Morningstar Mid-Cap ETFVO954.44M0.42%224.7B USD0.03%$81.03+0.78%
Invesco QQQ Trust, Series 1QQQ849.95M0.18%482.51B USD0.18%$714.88+0.87%
Vanguard Morningstar Growth ETFVUG523.07M0.14%372B USD0.03%$88.02+0.93%
iShares Core S&P 500 ETFIVV503.58M0.06%832.68B USD0.03%$767.92+0.84%
State Street SPDR S&P 500 ETFSPY488.66M0.06%799.37B USD0.09%$764.29+0.85%
Vanguard Morningstar Mid-Cap Growth ETFVOT337.22M1.00%33.5B USD0.05%$294.99+0.77%Vanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOInvesco QQQ Trust, Series 1QQQVanguard Morningstar Growth ETFVUGiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Mid-Cap Growth ETFVOTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
